It is important to monitor patients for adverse events at the start and during treatment. Immune related adverse events can also occur after treatment has stopped, so monitoring at this stage is also advised1. Patients need to be educated on how to monitor and identify symptoms associated with immune related adverse events.
Please ensure that you read the SmPC and that patients are provided with the Patient Information Booklet and Patient Alert Card, Risk Minimisation Materials2,3. If you have any queries relating to these materials, please contact MSD Medical Information at medinfo_ireland@merck.com or ring +353 (01) 2998700 and select from the options on the recorded message.
